Regular monitoring of nutritional status, hydration, weight trajectory, and functional capacity can help maximize the benefits of GLP-1 therapy while minimizing nutrition-related complications in older adults
Metformin is taken daily, usually with breakfast and dinner
The 4mg dose produced an average weight loss of 17.1% at 48 weeks in the clinical trial
See my options Quick answer Retatrutide (Eli Lilly) is a triple agonist (GLP-1, GIP, and glucagon) in Phase 3, with reported weight loss around 28% to 30% at higher doses, the strongest of the group so far
To explore if compounded semaglutide is right for you, take our free assessment quiz
Lets explore the science behind these medications and how they help curb cravings and food noise